In today’s post:
💉 What Replaces Covid Cash?
💉 What Replaces Covid Cash?
Pfizer $PFE ( ▲ 1.7% ) made $11 billion from COVID in 2024. It's guiding for $5 billion in 2026.
That's a six billion dollar hole, dug in three years, by a company that isn't allowed to look panicked about it.
But is the rest of Pfizer growing fast enough to make that hole irrelevant?
The stock is down over 6% in the last 6 months so the the market's current answer is "prove it."
Let's go through the evidence.
Subscribe to Daily Bull Run Premium+ to read the rest.
Every day we hand you at least one stock that should outperform — backed by research, charts, and a clear “why now.” No hype. No guessing. Just real analysis built to make you money.
UpgradeA subscription gets you:
- 📈 High-conviction stock picks every day — researched, explained, and timed for maximum impact
- 🧠 Deep-dive analysis — no fluff, just the “why it’s a winner” broken down clearly
- ⏳ Save hours of research — we do the digging, you get the insights
- 🧭 Clear buy thesis & risks — no vague calls, just full transparency
- 🔒 Early access to picks — before we even hint at them publicly
- 🏆 Designed to help you outperform — not just “inform” you
- 🔥 Zero hype. No jargon. Just real signals.
